4//SEC Filing
Schwarzer Fred 4
Accession 0001209191-22-058911
CIK 0001496323other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 8:30 PM ET
Size
8.2 KB
Accession
0001209191-22-058911
Insider Transaction Report
Form 4
Schwarzer Fred
DirectorCEO and President
Transactions
- Sale
Common Stock
2022-11-23$21.99/sh−397$8,731→ 32,729 total - Sale
Common Stock
2022-11-23$21.38/sh−861$18,405→ 33,126 total
Holdings
- 196,718(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001787361
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 8:30 PM ET
- Size
- 8.2 KB